F.L. Putnam Investment Management’s ResMed RMD Stock Holding History

F.L. Putnam Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Sell	5,358 -188	-3%	-$39K	0.01%	363
2026 Q1	$1.24M	Sell	5,546 -743	-12%	-$185K	0.02%	300
2025 Q4	$1.51M	Buy	6,289 +258	+4%	+$66K	0.02%	284
2025 Q3	$1.65M	Hold	6,031	–	–	0.02%	276
2025 Q2	$1.56M	Buy	6,031 +76	+1%	+$18.1K	0.03%	272
2025 Q1	$1.33M	Buy	5,955 +300	+5%	+$70K	0.03%	285
2024 Q4	$1.29M	Sell	5,655 -1,781	-24%	-$429K	0.02%	286
2024 Q3	$1.38M	Buy	7,436 +321	+5%	+$71.7K	0.02%	290
2024 Q2	$1.36M	Buy	+7,115	New	+$1.44M	0.03%	286

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

F.L. Putnam Investment Management's RMD Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its ResMed (RMD) stake by 3.4% in Q2 2026, selling an estimated $39K and leaving 5,358 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #363.

F.L. Putnam Investment Management first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.65M in Q3 2025. 517 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

F.L. Putnam Investment Management held 5,358 shares of ResMed worth $1.04M as of Q2 2026.
F.L. Putnam Investment Management sold 188 ResMed shares in Q2 2026, an estimated $39K.
ResMed made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #363 holding.
F.L. Putnam Investment Management first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
F.L. Putnam Investment Management's ResMed position peaked at $1.65M in Q3 2025.
517 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.